Terms: = Liver cancer AND STIL, SIL, 6491, ENSG00000123473, Q15468 AND Prognosis
13 results:
1. Elevated stil predicts poor prognosis in patients with hepatocellular carcinoma.
Song H; Zhao H; Chen C; Zhang D; Wang X; He J
Medicine (Baltimore); 2023 Feb; 102(7):e33004. PubMed ID: 36800576
[TBL] [Abstract] [Full Text] [Related]
2. Elevated soluble programmed death-ligand 1 levels indicate immunosuppression and poor prognosis in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization.
Ma XL; Qu XD; Yang WJ; Wang BL; Shen MN; Zhou Y; Zhang CY; Sun YF; Chen JW; Hu B; Gong ZJ; Zhang X; Pan BS; Zhou J; Fan J; Yang XR; Guo W
Clin Chim Acta; 2020 Dec; 511():67-74. PubMed ID: 32979338
[TBL] [Abstract] [Full Text] [Related]
3. Intratumoral infiltrating lymphocytes correlate with improved survival in colorectal cancer patients: Independent of oncogenetic features.
Nazemalhosseini-Mojarad E; Mohammadpour S; Torshizi Esafahani A; Gharib E; Larki P; Moradi A; Amin Porhoseingholi M; Asadzade Aghdaei H; Kuppen PJK; Zali MR
J Cell Physiol; 2019 Apr; 234(4):4768-4777. PubMed ID: 30370522
[TBL] [Abstract] [Full Text] [Related]
4. Clinical significance of serum soluble T cell regulatory molecules in clear cell renal cell carcinoma.
Masuda A; Arai K; Nishihara D; Mizuno T; Yuki H; Kambara T; Betsunoh H; Abe H; Yashi M; Fukabori Y; Yoshida K; Kamai T
Biomed Res Int; 2014; 2014():396064. PubMed ID: 25089268
[TBL] [Abstract] [Full Text] [Related]
5. cancer biomarker profiling in patients with chronic hepatitis C virus, liver cirrhosis and hepatocellular carcinoma.
Costantini S; Capone F; Maio P; Guerriero E; Colonna G; Izzo F; Castello G
Oncol Rep; 2013 Jun; 29(6):2163-8. PubMed ID: 23564159
[TBL] [Abstract] [Full Text] [Related]
6. Primary hepatic peripheral T-cell lymphoma treated with corticosteroid.
Miyashita K; Tomita N; Oshiro H; Matsumoto C; Nakajima Y; Ito S; Matsumoto K; Fujita H; Ishigatsubo Y
Intern Med; 2011; 50(6):617-20. PubMed ID: 21422689
[TBL] [Abstract] [Full Text] [Related]
7. Twenty-year experience with liver transplantation for hepatocellular carcinoma.
Island ER; Pomposelli J; Pomfret EA; Gordon FD; Lewis WD; Jenkins RL
Arch Surg; 2005 Apr; 140(4):353-8. PubMed ID: 15837885
[TBL] [Abstract] [Full Text] [Related]
8. [Prognostic factors in patients with small cell lung cancer].
Song LH; Song XR; Zhang XQ; Qi JL; Li XJ; Tian H; Bu B
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):413-6. PubMed ID: 15355646
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic value of serum biological markers in patients with hepatocellular carcinoma.
Parasole R; Izzo F; Perrone F; Pignata S; Galati MG; Leonardi E; Castiglione F; Orlando R; Castello G; Esposito G; Gallo C; Daniele B
Clin Cancer Res; 2001 Nov; 7(11):3504-9. PubMed ID: 11705869
[TBL] [Abstract] [Full Text] [Related]
10. Serum adhesion molecules and interleukin-2 receptor as markers of tumour load and prognosis in advanced cutaneous melanoma.
Vuoristo MS; Laine S; Huhtala H; Parvinen LM; Hahka-Kemppinen M; Korpela M; Kumpulainen E; Kellokumpu-Lehtinen P
Eur J Cancer; 2001 Sep; 37(13):1629-34. PubMed ID: 11527688
[TBL] [Abstract] [Full Text] [Related]
11. [Clinical study of infection associated hemophagocytic syndrome].
Shiraishi K; Tanaka K; Okubo Y; Sakamoto A; Jojima H; Fukahori S; Fujimatsu Y; Shiraishi T; Honda J; Oizumi K
Kansenshogaku Zasshi; 2000 Aug; 74(8):630-7. PubMed ID: 11019510
[TBL] [Abstract] [Full Text] [Related]
12. [Changes in serum IL-2 and sil-2R levels in patients with primary hepatic carcinoma before and after treatment and their clinical significance].
Wang M; Feng Y; Zhou X
Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):33-5. PubMed ID: 7656784
[TBL] [Abstract] [Full Text] [Related]
13. [Dynamic studies of NK activity, IL-2 production and sil-2R expression in primary hepatic carcinoma patients before and after operation].
Cao YY
Zhonghua Zhong Liu Za Zhi; 1993 Mar; 15(2):111-3. PubMed ID: 8223118
[TBL] [Abstract] [Full Text] [Related]
